Who is the new Chief Technology Officer at Immunome Inc?

Immunome Inc. named Phil Tsai Chief Technology Officer, announced June 27, 2024.

Which similar companies made leadership changes around the same time?

Actym Therapeutics (June 25, 2024), Medical Technology Enterprise Consortium (MTEC) (June 14, 2024), NYU Langone Health (July 25, 2024) and Pulse Biosciences, Inc. (May 14, 2024) also announced leadership changes within 45 days of Immunome Inc.

Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer

PUBLIC · IMNMJun 27, 2024

Position

Chief Technology Officer

Company

Immunome Inc.

Phil Tsai

ptsai@immunome.com

BothellBiotechnologyHealth CareMedicalTherapeutics

Description

Immunome, Inc. announced the appointment of Phil Tsai, PhD, as Chief Technical Officer

Quick answer

Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer (June 27, 2024). Immunome Inc. is based in Bothell, Washington, United States.

Who is the new Chief Technology Officer at Immunome Inc?: Immunome Inc. named Phil Tsai Chief Technology Officer, announced June 27, 2024.
What did Immunome Inc. announce on June 27, 2024?: Immunome, Inc. announced the appointment of Phil Tsai, PhD, as Chief Technical Officer
What does Immunome Inc. do?: Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies.
Where is Immunome Inc. based?: Immunome Inc. is based in Bothell, Washington, United States.
Which similar companies made leadership changes around the same time?: Actym Therapeutics (June 25, 2024), Medical Technology Enterprise Consortium (MTEC) (June 14, 2024), NYU Langone Health (July 25, 2024) and Pulse Biosciences, Inc. (May 14, 2024) also announced leadership changes within 45 days of Immunome Inc.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Immunome Inc., and when

A new leader at Immunome Inc. brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day Immunome Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Immunome Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunome Inc.. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunome Inc.

Location

665 STOCKTON DRIVE

Bothell, Washington, United States

About

Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies and antibody drug conjugates (ADCs). We believe that pursuing underexplored targets with appropriate drug modalities leads to transformative therapies. Our proprietary memory B cell hybridoma technology allows for the rapid screening and functional characterization of novel antibodies and targets. Immunome is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, or other applicable legally protected characteristics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunome Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans